Chromatics Color Sciences (CCSI)--Non-Flaming Discussion Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences (CCSI)--Non-Flaming Discussion

CCSI 26.66

-1.8%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stephen Kahn who wrote (1)	5/14/1998 12:03:00 AM
From: jpbrody	Read Replies (1) of 44

Someone on the yahoo board pointed out this link: spectrx.com It's an analysis by Hambrecht and Quist of SpectRx, a competitor to CCSI. I also found a summary of the report at hamquist.com if you don't have the capability to read pdf files. Here's an excerpt: "In the United States alone, an estimated 1.7 million newborns receive at least one blood test to measure bilirubin. The worldwide market for bilirubin testing is an estimated $180 million annually at an average of $10 per test. " "SpectRx receives an average of approximately $2.00 for each disposable. With a potential U.S. market of 6 million tests per year, the disposable product addresses a potential market of $15 million. The measurement instrument should sell to the end-user for around $4,000 and make up the bulk of revenues for at least a few years. " I believe that these are realistic numbers that should also pertain to CCSI. There is still, of course, a question of market share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next